Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (11-20 of 221) with videos related to

Pageof 23
Sort By:
Pharmaceutics|June 28, 2023
Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat StudyMedha D Joshi, Paulina Iacoban, Marc H Scheetz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2021
Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than AnswersSean N Avedissian, Marc H Scheetz, Nicolás Cortés-Penfield
Journal of Clinical Microbiology|January 25, 2008
Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007Chao Qi, Michael Malczynski, Michelle Parker, et al.
Open Forum Infectious Diseases|April 30, 2025
Response to Cojutti and Pea, "Is it Time to Move From Intermittent to Continuous Infusion Administration of Vancomycin?"Justin Shiau, Sharmeen Roy, Paul Sabourenkov, et al.
Pharmacotherapy|December 28, 2020
Vancomycin Area Under the Curve-guided Dosing and Monitoring: "Is the Juice Worth the Squeeze"?Thomas P Lodise, Ronald G Hall, Marc H Scheetz
The Annals of Pharmacotherapy|August 21, 2008
Posaconazole: an oral triazole with an extended spectrum of activityErik J Rachwalski, Jeffrey T Wieczorkiewicz, Marc H Scheetz
Journal of Critical Care|October 21, 2015
Periarrest intestinal bacterial translocation and resuscitation outcomeAthanasios Chalkias, Marc H Scheetz, Anil Gulati, et al.
Open Forum Infectious Diseases|March 12, 2025
Big Data Bayesian Truths: No Vancomycin Trough Concentration Target Is Sufficiently Precise for Safety or EfficacyJustin Shiau, Sharmeen Roy, Paul Sabourenkov, et al.
Pharmacotherapy|March 26, 2010
Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene statusJohn S Esterly, Chao Qi, Michael Malczynski, et al.
International Journal of Antimicrobial Agents|April 4, 2022
A translational rat model to assess glomerular function changes with vancomycinGwendolyn M Pais, Jack Chang, Jiajun Liu, et al.
Pageof 23

Showing results (11-20 of 221) with videos related to

Sort By:
Pageof 23
Pharmaceutics|June 28, 2023
Pharmacokinetic and Biomarker Quantification Studies on Vancomycin-Loaded PEGylated Liposomes and Its Potential to Reduce Vancomycin-Induced Kidney Injury: A Rat StudyMedha D Joshi, Paulina Iacoban, Marc H Scheetz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 19, 2021
Early Switch From Vancomycin to Daptomycin in Methicillin-Resistant Staphylococcus aureus Bacteremia: Still More Questions Than AnswersSean N Avedissian, Marc H Scheetz, Nicolás Cortés-Penfield
Journal of Clinical Microbiology|January 25, 2008
Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007Chao Qi, Michael Malczynski, Michelle Parker, et al.
Open Forum Infectious Diseases|April 30, 2025
Response to Cojutti and Pea, "Is it Time to Move From Intermittent to Continuous Infusion Administration of Vancomycin?"Justin Shiau, Sharmeen Roy, Paul Sabourenkov, et al.
Pharmacotherapy|December 28, 2020
Vancomycin Area Under the Curve-guided Dosing and Monitoring: "Is the Juice Worth the Squeeze"?Thomas P Lodise, Ronald G Hall, Marc H Scheetz
The Annals of Pharmacotherapy|August 21, 2008
Posaconazole: an oral triazole with an extended spectrum of activityErik J Rachwalski, Jeffrey T Wieczorkiewicz, Marc H Scheetz
Journal of Critical Care|October 21, 2015
Periarrest intestinal bacterial translocation and resuscitation outcomeAthanasios Chalkias, Marc H Scheetz, Anil Gulati, et al.
Open Forum Infectious Diseases|March 12, 2025
Big Data Bayesian Truths: No Vancomycin Trough Concentration Target Is Sufficiently Precise for Safety or EfficacyJustin Shiau, Sharmeen Roy, Paul Sabourenkov, et al.
Pharmacotherapy|March 26, 2010
Predictability of doripenem susceptibility in Acinetobacter baumannii isolates based on other carbapenem susceptibilities and bla OXA gene statusJohn S Esterly, Chao Qi, Michael Malczynski, et al.
International Journal of Antimicrobial Agents|April 4, 2022
A translational rat model to assess glomerular function changes with vancomycinGwendolyn M Pais, Jack Chang, Jiajun Liu, et al.
Pageof 23